News
2h
Zacks Investment Research on MSNLilly Down 17% Since Q1 Results: Should You Buy the Dip in LLY Stock?Eli Lilly and Company’s LLY shares have lost 17% so far in May. Lilly announced mixed earnings results on May 1. It missed ...
With the active ingredients in drugs like Ozempic and Zepbound no longer in shortage, access to medicine for millions who had ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results